Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Infectious Disease

Life After the Hospital: Staying in Remission

At a Glance

The most effective way to prevent a melioidosis relapse is strictly completing the entire 12-week oral antibiotic eradication phase, even after symptoms disappear. Managing blood sugar levels and avoiding soil or stagnant water are also critical for long-term remission.

Entering the recovery phase of melioidosis is a significant milestone, but it is not the end of the journey. Because Burkholderia pseudomallei is so adept at hiding within your body, the “eradication” phase is just as important as the time you spent in the hospital [1]. Success depends on your vigilance, your commitment to the medication, and the long-term management of your underlying health [2][3].

Relapse vs. Reinfection

It is important to understand the difference between a relapse and a reinfection [4]. Both are risks that require you to stay vigilant.

  • Relapse: This happens when the original infection “wakes up” because the treatment plan was interrupted or stopped too early [5]. You are at a higher risk for relapse if you had bacteria in your blood, brain, or deep-seated abscesses in organs like the liver or prostate [6][7].
  • Reinfection: This occurs when you catch a completely new strain of the bacteria from the environment after you have already been cured [4].
  • Adherence is Shielding: The single most effective way to prevent a relapse is to finish every single dose of your 12-week (or longer) oral antibiotic course, even when you feel completely healthy [2][8].

Monitoring and Surveillance Schedule

Because this bacterium can be dormant, your doctors will likely use a combination of blood tests and imaging to monitor your progress [7][9].

  1. Imaging Follow-ups: If you had abscesses in your internal organs, you may need follow-up ultrasounds or CT scans [7]. These scans help confirm that the pockets of infection are shrinking or have turned into harmless scar tissue.
  2. Blood Work: While on long-term oral antibiotics, you will need regular blood tests (often every 2–4 weeks) to monitor your kidney function, potassium levels, and blood counts [10][11].
  3. Clinical Exams: Your doctor will look for the return of “The Great Imitator’s” symptoms, such as new fevers, night sweats, or unexplained weight loss [9].

Diabetes: Your Most Important Management Tool

If you have diabetes, your blood sugar level is directly tied to your risk of relapse [12][13]. High blood sugar acts as a “green light” for the bacteria, weakening the immune cells that are supposed to keep them in check [14][15].

  • Prognosis: Patients who maintain stable, healthy blood sugar levels generally have a much better long-term outlook and a lower risk of the infection returning [16][12].
  • Consistency: Recovery is a marathon. Working closely with an endocrinologist or primary care doctor to manage your HbA1c is a vital part of your melioidosis care plan [12][16].

Navigating the Eradication Phase

The 12-week oral phase can be challenging. Many patients experience side effects like nausea, skin rashes, or a general feeling of being unwell [17][9].

  • Quality of Life: It is common to feel frustrated by the long duration of treatment. Some patients find that taking their medication with food or at specific times of day helps reduce stomach upset [17]. If you experience a new rash or severe vomiting, do not simply stop the medication. Contact your doctor immediately to discuss a “Plan B” so that your eradication therapy remains continuous [17][18].
  • Returning to Life: You can usually return to work and daily activities once you have completed the IV phase and feel strong enough. However, you should avoid activities that involve direct contact with soil or stagnant water (like gardening or wading in ponds) while your immune system is still recovering [19][20].
  • Long-Term Precautions: Once you are fully healed, if you do return to gardening or outdoor work, you must wear protective gear like waterproof boots and thick gloves to prevent reinfection from the environment [21][22].

Return to the Home Page

Common questions in this guide

What is the difference between a melioidosis relapse and a reinfection?
A relapse occurs when the original infection reactivates, often because treatment was interrupted or stopped too early. A reinfection happens when you are exposed to a completely new strain of the bacteria from the environment after your initial infection was cured.
Why is diabetes management important during melioidosis recovery?
High blood sugar weakens the immune cells that keep the bacteria in check, acting like a 'green light' for the infection to return. Maintaining stable, healthy blood sugar levels significantly lowers your risk of relapse and improves your long-term prognosis.
How long do I need to take oral antibiotics for melioidosis?
The oral eradication phase typically lasts at least 12 weeks. It is absolutely crucial to finish every single dose, even if you feel completely healthy, to ensure any dormant bacteria are fully eliminated.
What should I do if the antibiotics make me feel sick?
If you experience side effects like nausea, skin rashes, or vomiting, do not simply stop your medication. Contact your doctor immediately to discuss a plan to manage the side effects so your eradication therapy remains continuous.
When is it safe to return to gardening or outdoor work?
While your immune system is recovering, you should avoid activities involving direct contact with soil or stagnant water. Once you are fully healed and cleared by your doctor, you must wear protective gear like waterproof boots and thick gloves to prevent reinfection.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific criteria will we use to decide if my 12-week eradication phase should be extended?
  2. 2.How often do I need follow-up ultrasounds or CT scans to monitor the abscesses in my organs?
  3. 3.What is the most effective way to manage my blood sugar specifically during this recovery period?
  4. 4.What blood markers (like inflammatory markers or liver/kidney tests) are we tracking to ensure I’m staying in remission?
  5. 5.Are there any specific symptoms—like a new fever or night sweats—that should trigger an immediate visit?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.

    Webb JR, Price EP, Currie BJ, Sarovich DS

    Antimicrobial agents and chemotherapy 2017; (61(6)) doi:10.1128/AAC.00268-17.

    PMID: 28348161
  2. 2

    Oral eradication therapy for melioidosis: Important but not without risks.

    Sullivan RP, Ward L, Currie BJ

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2019; (80()):111-114 doi:10.1016/j.ijid.2019.01.019.

    PMID: 30659921
  3. 3

    Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates.

    Fen SHY, Tandhavanant S, Phunpang R, et al.

    Antimicrobial agents and chemotherapy 2023; (95(5)) doi:10.1128/AAC.02230-20.

    PMID: 33593842
  4. 4

    Bone and joint infections due to melioidosis; diagnostic and management strategies to optimise outcomes.

    Dadwal P, Bonner B, Fraser D, et al.

    PLoS neglected tropical diseases 2024; (18(7)):e0012317 doi:10.1371/journal.pntd.0012317.

    PMID: 39018296
  5. 5

    Rare Neuromelioidosis Case that Required Long Intensive Phase Therapy.

    Ankala S, John T, Varghese B

    Oman medical journal 2025; (40(3)):e760 doi:10.5001/omj.2025.14.

    PMID: 41244001
  6. 6

    The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia-Implications for Clinical Management.

    Prinsloo C, Smith S, Law M, Hanson J

    Tropical medicine and infectious disease 2023; (8(11)) doi:10.3390/tropicalmed8110481.

    PMID: 37999600
  7. 7

    Hepatic/splenic abscess and/or skin and soft tissue infection as predictors of melioidosis in children.

    Chanvitan S, Geater A, Laoprasopwattana K

    Journal of infection in developing countries 2019; (13(2)):149-153 doi:10.3855/jidc.10727.

    PMID: 32036350
  8. 8

    A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial.

    Anunnatsiri S, Chaowagul W, Teparrukkul P, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; (73(11)):e3627-e3633 doi:10.1093/cid/ciaa1084.

    PMID: 32725199
  9. 9

    Treatment of Melioidosis.

    Meumann EM, Rajahram G, Woolley SD, et al.

    Infectious disease clinics of North America 2026; (40(1)):127-147 doi:10.1016/j.idc.2025.12.002.

    PMID: 41571490
  10. 10

    Drug-induced renal tubular acidosis in a patient receiving trimethoprim-sulfamethoxazole.

    Tan HL, Ee SCE, Zhao Y, Lew PS

    BMJ case reports 2025; (18(1)) doi:10.1136/bcr-2024-263500.

    PMID: 39875144
  11. 11

    Analysis of the Clinical Characteristics of Hyponatremia Induced by Trimethoprim/Sulfamethoxazole.

    Lei H, Liu X, Zeng J, et al.

    Pharmacology 2022; (107(7-8)):351-358 doi:10.1159/000523824.

    PMID: 35381593
  12. 12

    Quantitative Proteomics Reveals Differences in the Response of Neutrophils Isolated from Healthy or Diabetic Subjects to Infection with Capsule-Variant Burkholderia thailandensis.

    Withatanung P, Kurian D, Tangjittipokin W, et al.

    Journal of proteome research 2019; (18(7)):2848-2858 doi:10.1021/acs.jproteome.9b00166.

    PMID: 31244210
  13. 13

    Burkholderia pseudomallei sepsis with osteoarticular melioidosis of the hip in a patient with diabetes mellitus.

    Boyer PN, Woods ML

    BMJ case reports 2020; (13(12)) doi:10.1136/bcr-2020-238200.

    PMID: 33370949
  14. 14

    Dysfunctional host cellular immune responses are associated with mortality in melioidosis.

    Wright SW, Ekchariyawat P, Sengyee S, et al.

    Emerging microbes & infections 2024; (13(1)):2380822 doi:10.1080/22221751.2024.2380822.

    PMID: 39008280
  15. 15

    Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.

    Trevino SR, Dankmeyer JL, Fetterer DP, et al.

    PLoS neglected tropical diseases 2021; (15(2)):e0009125 doi:10.1371/journal.pntd.0009125.

    PMID: 33571211
  16. 16

    The Epidemiology of Melioidosis and Its Association with Diabetes Mellitus: A Systematic Review and Meta-Analysis.

    Chowdhury S, Barai L, Afroze SR, et al.

    Pathogens (Basel, Switzerland) 2022; (11(2)) doi:10.3390/pathogens11020149.

    PMID: 35215093
  17. 17

    Adverse reactions to trimethoprim/sulfamethoxazole for melioidosis eradication therapy: An evaluation of frequency and risk factors.

    Martin GE, Bramwell J, Gadil E, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2025; (150()):107283 doi:10.1016/j.ijid.2024.107283.

    PMID: 39521392
  18. 18

    Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis.

    Puing AG, Epstein DJ, Banaei N, et al.

    Emerging infectious diseases 2021; (27(10)):2734-2736 doi:10.3201/eid2710.210620.

    PMID: 34545802
  19. 19

    Land use and soil type determine the presence of the pathogen Burkholderia pseudomallei in tropical rivers.

    Ribolzi O, Rochelle-Newall E, Dittrich S, et al.

    Environmental science and pollution research international 2016; (23(8)):7828-39 doi:10.1007/s11356-015-5943-z.

    PMID: 26758304
  20. 20

    Genomic Epidemiology Links Burkholderia pseudomallei from Individual Human Cases to B. pseudomallei from Targeted Environmental Sampling in Northern Australia.

    Webb JR, Mayo M, Rachlin A, et al.

    Journal of clinical microbiology 2022; (60(3)):e0164821 doi:10.1128/JCM.01648-21.

    PMID: 35080450
  21. 21

    Seroprevalence of Burkholderia pseudomallei among Adults in Coastal Areas in Southwestern India.

    Vandana KE, Mukhopadhyay C, Tellapragada C, et al.

    PLoS neglected tropical diseases 2016; (10(4)):e0004610 doi:10.1371/journal.pntd.0004610.

    PMID: 27078156
  22. 22

    Presence of Burkholderia pseudomallei in Soil and Paddy Rice Water in a Rice Field in Northeast Thailand, but Not in Air and Rainwater.

    Ong CEL, Wongsuvan G, Chew JSW, et al.

    The American journal of tropical medicine and hygiene 2017; (97(6)):1702-1705 doi:10.4269/ajtmh.17-0515.

    PMID: 29016340

This page provides educational information about the melioidosis recovery and eradication phase. Always consult your infectious disease specialist before making any changes to your antibiotic regimen or recovery plan.

Get notified when new evidence is published on Melioidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.